Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.

ICICI Prudential Mutual Fund

ICICI Prudential Nifty Pharma Index Fund - Direct Plan - IDCW

★★★★★ 3rd-party

External rating

  • Source: Third-party data provider (Groww/CRISIL)
  • Original rating: 2/5, displayed as-is — TopFund does not modify third-party ratings
  • Refresh frequency: Whenever TopFund re-syncs this fund's data
  • Limitations: The provider's own rating methodology isn't disclosed here — see the provider's own site for their criteria

Full rating methodology →

TopFund Score: 71/100 · Good

How this score is calculated

  • Star rating (35%)2/5
  • 3Y CAGR (30%)21.36%
  • Expense ratio (20%)0.51%
  • AUM (15%)₹163 Cr

Not investment advice — an analytical read of public fund data. Methodology →

ICICI Prudential Mutual Fund · Other · Index Funds

₹21.83

+0.03 (+0.15%)

AUM: ₹163 Cr

NAV updated about 22 hours ago

Plan

Direct

Option

Idcw

Risk

High

Expense Ratio

0.51%

Exit Load

Nil

Fund Manager

Nishit Patel

Inception

Dec 2022

Benchmark

NIFTY Pharma Total Return Index

Sharpe Ratio

1.25

Std Dev (1Y)

14.66%

Historical Returns (CAGR)

Annualized trailing returns computed from NAV history — past performance only, not a guarantee of future results.

1m

+9.35%

3m

+6.9%

6m

+14.06%

1y

+24.29%

3y

+21.36%

5y

—

10y

—

since inception

+22.18%

TopFund's Take on ICICI Prudential Nifty Pharma Index Fund - Direct Plan - IDCW

ICICI Prudential Nifty Pharma Index Fund - Direct Plan - IDCW holds up reasonably well within the Index Funds category, currently carrying a 2-star rating. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 71/100.

Cost: At 0.51%, the expense ratio runs 31% above the Index Funds category average of 0.39%. That gap is worth weighing against the fund's actual performance versus cheaper peers before committing to a long SIP.

Risk-adjusted performance: Over the trailing 1-year period, the fund shows a strong Sharpe ratio of 1.25 — the fund has generated solid returns relative to the volatility it exposed investors to. Separately, annualised volatility of 14.66% is fairly typical for Index Funds funds.

Who should invest: This fund is best suited to cost-conscious investors happy to simply match the market rather than try to beat it. The High risk rating means near-term volatility should be expected — this isn't a fund to check daily.

This is an automated, data-driven analysis based on the fund's own metrics and its category peers — not personalized investment advice. Consult a SEBI-registered advisor before investing.

Sector Allocation

Healthcare 99.93%

Asset Allocation

Equity 99.93%
Repo 1.50%

Frequently Asked Questions about ICICI Prudential Nifty Pharma Index Fund - Direct Plan - IDCW

* Past performance is not indicative of future results. Mutual fund investments are subject to market risks.

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

No comments yet — start the discussion.